Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity Ritter ML; Pirofski LTranspl Infect Dis 2009[Aug]; 11 (4): 290-7Mycophenolate mofetil (MMF) is one of the most frequently used immunosuppressive drugs in solid organ transplant recipients. MMF is an inhibitor of inosine-5'-monophosphate, and is able to preferentially inhibit B-cell and T-cell function. The immunosuppressive abilities of MMF have made it one of the most successful anti-rejection drugs in transplant patients, but patients also appear to have increased susceptibility to infections, specifically cytomegalovirus and BK virus. Despite its association with an increased risk of infection, MMF has also exhibited antimicrobial activity against pathogens including hepatitis C, Pneumocystis jirovecii, and human immunodeficiency virus. A thorough understanding of the functions of MMF on the immune system and interaction with infectious pathogens could be helpful in implementing preventative strategies against opportunistic infections in transplant patients.|Animals[MESH]|Antifungal Agents/*pharmacology[MESH]|Antiviral Agents/*pharmacology[MESH]|B-Lymphocytes/*drug effects/immunology[MESH]|Clinical Trials as Topic[MESH]|Graft Rejection/prevention & control[MESH]|Humans[MESH]|Immunosuppressive Agents/administration & dosage/pharmacology/*therapeutic use[MESH]|Mice[MESH]|Mycophenolic Acid/administration & dosage/*analogs & derivatives/pharmacology/therapeutic use[MESH]|Opportunistic Infections/microbiology/*prevention & control/virology[MESH]|Organ Transplantation/*adverse effects[MESH]|Pneumocystis/drug effects[MESH]|Rats[MESH]|T-Lymphocytes/*drug effects/immunology[MESH]|Viruses/drug effects[MESH] |
